Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (U-SMART)

This study has been completed.
Sponsor:
Collaborator:
KT corporation
Information provided by (Responsible Party):
Ki Woong Kim, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT01628653
First received: June 23, 2012
Last updated: NA
Last verified: June 2012
History: No changes posted

June 23, 2012
June 23, 2012
June 2011
February 2012   (final data collection date for primary outcome measure)
  • the five-point Likert scales for satisfaction and compliance [ Time Frame: after 4-weeks treatment ] [ Designated as safety issue: No ]
    To evaluate the feasibility of the U-SMART, the five-point Likert scales for satisfaction and compliance were applied to all participants.
  • Word List Memory Test of the CERAD Neuropsychological Assessment Battery [ Time Frame: after 4-weeks treatment ] [ Designated as safety issue: No ]
    To evaluate the efficacy of the U-SMART, the Word List Memory Test (WLMT) of the CERAD neuropsychological assessment battery was applied to all participants.
Same as current
No Changes Posted
Mini-Mental State Examination (MMSE) [ Time Frame: after 4-weeks treatment ] [ Designated as safety issue: No ]
Same as current
 
 
 
Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training
Feasibility and Efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (U-SMART) on Mild Cognitive Impairment

The purpose of this study is to examine feasibility and efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (U-SMART) in the elderly individuals with mild cognitive impairment (MCI).

The Spaced Retrieval-based Memory Advancement and Rehabilitation Training (SMART) which consisted of 24 one-hour face-to-face sessions (Lee, Park et al. 2009) was developed based on the spaced retrieval training (SRT), which was effective in improving memory retention span of very mild to mild Alzheimer's disease patients. The Ubiquitous SMART (U-SMART) by transforming the current SMART to a self-administered program using an application working on IPAD was developed, and was examined its feasibility and efficacy in the elderly individuals with mild cognitive impairment.

Interventional
Phase 1
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Mild Cognitive Impairment
Device: U-SMART
4-weeks' training
Experimental: U-SMART
U-SMART (Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training)
Intervention: Device: U-SMART
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
10
February 2012
February 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Aged 55-90
  • Educational level above 1 year and confirmed literacy
  • Diagnosed to mild cognitive impairment by International Working Group on Mild Cognitive Impairment
  • Clinical Dementia Rating (CDR) of 0 or 0.5

Exclusion Criteria:

  • Diagnosed to dementia by DSM-IV
  • Evidence of delirium, confusion
  • Any neurological conditions causing cognitive decline such as Parkinson's disease, brain hemorrhage, brain tumor, normal pressure hydrocephalus
  • Evidence of severe cerebrovascular pathology
  • History of loss-of-consciousness over 1 hour due to head trauma or repetitive head trauma of mild severity
  • History of substance abuse or dependence such as alcohol
  • Presence of depressive symptoms that could influence cognitive function
  • Presence of medical comorbidities that could result in cognitive decline
  • Use of medication that could influence cognitive function seriously
Both
55 Years to 90 Years
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT01628653
06-2011-084
Yes
Ki Woong Kim, Seoul National University Bundang Hospital
Seoul National University Bundang Hospital
KT corporation
Principal Investigator: Ki Woong Kim, M.D., Ph.D. Seoul National University Bundang Hospital, Seong-nam, Korea
Seoul National University Bundang Hospital
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP